Prediction Case File
YouTubeEvaluation Complete

Friends! In This Video, Im going to analyze Marvell Technology Stock and discuss the risks and upside potential of MRVL stock

2 extracted signals · 2 resolved · 0 still active

The Patient Investor profile imageThe Patient Investor08 Sept 2025, 22:36 UTC
Video preview for Friends! In This Video, Im going to analyze Marvell Technology Stock and discuss the risks and upside potential of MRVL stock
Signals
2
Eligible signals in this source
Open
0
Still being tracked
Resolved
2
Evaluable outcomes
Successful
2
Canonical correct result
Failed
0
Canonical failed result
Resolved success
100%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analysis discusses Marvell Technology (MRVL) and Broadcom (AVGO), focusing on a divergence in their year-to-date performance. MRVL is down 42% year-to-date, while AVGO is up 44%. The analysis mentions partnerships of Broadcom with OpenAI for custom AI chips, and of Marvell with Amazon Web Services and Microsoft. MRVL's revenue growth is reported at 58% year-on-year and 6% quarter-on-quarter, coming from Data Center, Enterprise Networking, Carrier Infrastructure, and Consumer segments. The Automotive business was sold for $2.5 billion, which the company intends to reinvest in the Data Center business. The guidance for Q3 projects flat sequential revenue. MRVL is highly dependent on Amazon Web Services for 76% of its data center revenue. The analysis discusses the company's profitability trends, noting it is unprofitable. MRVL depends a lot on China which is risky. For non-GAAP, MRVL is profitable, with a 20 times earnings forward PE ratio.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    2 eligible signals linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

The Patient Investor

Tracked signals
292
Historical success
32.9%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.